SERPINE1 and COVID-19: Similar results regarding hemostasis disorders in patients with COVID-19 were also reported by Hardy et al. [97], who investigated the following parameters: prothrombin time, heparin anti-Xa activity, fibrinogen, factor VIII activity, D-dimers, antithrombin and plasminogen activator inhibitor-I (PAI-1).